JAK2 and myeloproliferative disorder: The hypothesis of clonal heterogeneity in PMF is gaining increasing support as it was shown to be the main mechanism responsible for two different types of leukemic trans-formation seen in JAK2 mutation-positive myeloproliferative neoplasms, one with JAK2 mutation-positive blasts and one with JAK2 wild-type blasts.